Concourse Capital Management Lowers stake in Teladoc Inc (TDOC)

Teladoc Inc (TDOC) : Concourse Capital Management reduced its stake in Teladoc Inc by 55.58% during the most recent quarter end. The investment management company now holds a total of 21,977 shares of Teladoc Inc which is valued at $390,531 after selling 27,502 shares in Teladoc Inc , the firm said in a disclosure report filed with the SEC on Aug 2, 2016.Teladoc Inc makes up approximately 0.24% of Concourse Capital Management’s portfolio.

Other Hedge Funds, Including , Emerald Mutual Fund Advisers Trust boosted its stake in TDOC in the latest quarter, The investment management firm added 6,578 additional shares and now holds a total of 502,313 shares of Teladoc Inc which is valued at $8,760,339. Teladoc Inc makes up approx 0.46% of Emerald Mutual Fund Advisers Trust’s portfolio.Gradient Investments reduced its stake in TDOC by selling 26,986 shares or 97.95% in the most recent quarter. The Hedge Fund company now holds 566 shares of TDOC which is valued at $9,084.Cutler Group Lp reduced its stake in TDOC by selling 3,289 shares or 84.57% in the most recent quarter. The Hedge Fund company now holds 600 shares of TDOC which is valued at $9,684.

Teladoc Inc closed down -0.28 points or -1.68% at $16.36 with 5,38,116 shares getting traded on Monday. Post opening the session at $16.55, the shares hit an intraday low of $16.2 and an intraday high of $16.98 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Teladoc Inc reported $-0.38 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $-0.39. The company had revenue of $26.49 million for the quarter, compared to analysts expectations of $28.20 million. The company’s revenue was up 44.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.46 EPS.

Many Wall Street Analysts have commented on Teladoc Inc. Shares were Reiterated by Deutsche Bank on Aug 4, 2016 to “Buy” and Lowered the Price Target to $ 20 from a previous price target of $21 .Shares were Reiterated by FBR Capital on Aug 4, 2016 to “Outperform” and Lowered the Price Target to $ 28 from a previous price target of $34 .Shares were Reiterated by FBR Capital on Jul 20, 2016 to “Outperform” and Lowered the Price Target to $ 34 from a previous price target of $36 .

Teladoc Inc. is a telehealth company. The Company offers an on-demand healthcare platform through mobile devices Internet video and phone. Its solution connects consumers with physicians and behavioral health professionals or its providers who treat various conditions and cases from acute diagnoses such as upper respiratory infection urinary tract infection and sinusitis to dermatological conditions anxiety and smoking cessation. The Teladoc solution enables accessing on-demand healthcare for employers health plans and health systems. Its platform provides accessing physicians clinical programs and consumer engagement strategies. Its platform provides for interconnectivity between healthcare constituents. It offers solutions such as remote patient monitoring post-discharge treatment plan adherence and in-home and chronic care. Its customers also include channel partners such as brokers resellers and consultants who sell into a range of small medium and large enterprises.

Leave a Reply

Teladoc Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Teladoc Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.